Full-Time

Bloomington CQV/CSV Validation Engineers

Verista

Verista

201-500 employees

GxP lifecycle consulting for life sciences

No salary listed

Bloomington, IN, USA

In Person

Category
Biology & Biotech (2)
,

Get referred to Verista

See people who can refer or advise you

Requirements
  • 3+ years in validation engineering within pharmaceuticals or biotech.
  • Expertise in equipment qualification, Delta V, Upstream/Downstream process validation, GMP compliance, CIP/SIP, HVAC, or Utilities.
  • Based in or willing to relocate to Bloomington, IN.
  • Dedicated to delivering high-quality solutions that ensure patient safety and regulatory compliance.

Verista provides business and technology consulting for life science companies, focusing on systems, compliance, validation and quality across the GxP lifecycle. Its services cover preclinical, clinical, commercialization, manufacturing and distribution to ensure safe, high-quality results. The company combines decades of industry knowledge with advanced engagement platforms and transformative technologies to help clients solve complex challenges with one partner across specialties. With a team of 500+ experts, Verista supports clients from strategy and validation to execution, delivering consistent, compliant outcomes that improve health and lives. The goal is to enable better health outcomes by ensuring products and processes are safe, compliant and efficient throughout the product development lifecycle.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Fishers, Indiana

Founded

2020

Get referred to Verista

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Integral Solutions expands engineering and validation capacity across regulated life sciences operations.
  • INTERPHEX 2026 showcased COUNTQ and KITQ to drugmakers, CMOs, and medical-device teams.
  • Sware partnership and Laferrera's arrival signal continued digital-validation and acquisition-driven expansion.

What critics are saying

  • Verista faces ERISA and employment litigation in 2026, distracting management and increasing legal costs.
  • Acquiring Integral Solutions in 2026 risks integration failures, customer churn, and margin compression.
  • Private-equity-backed services firms die when utilization slips; Verista depends on project demand.

What makes Verista unique

  • Verista bundles CSV, commissioning, automation, and compliance across the full GxP lifecycle.
  • COUNTQ and KITQ target packaging reconciliation with AI, RFID, and Part 11 controls.
  • Michael Laferrera's August 2026 CEO appointment adds M&A and pharma-services operating discipline.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Paid Parental Leave

Bereavement Leave

Tuition Reimbursement

Company Social Events

Employee Referral Bonus

Commuter Benefits

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-1%
Pharmaceutical Technology
Jul 31st, 2026
Verista expands automation and validation capabilities with acquisition of Integral Solutions.

Verista expands automation and validation capabilities with acquisition of Integral Solutions. 31 July 2026 Verista, a leading provider of automation, compliance, and quality solutions for the life sciences industry, announced the acquisition of Integral Solutions. Based in Columbus, OH, Integral Solutions is a life sciences business and technology services firm that specializes in engineering and validation services worldwide. The acquisition enhances Verista's capabilities in automation, engineering, project management, and validation, enabling the company to deliver further comprehensive support across the full lifecycle of regulated life sciences operations. Founded in 1997 by Lou Seich, Integral Solutions built a strong reputation for delivering high-quality engineering and validation services, grounded in a commitment to client success, a passion for employee growth, and a culture of continuous improvement. The company's team of engineering, project management, and validation professionals supported clients globally with turnkey validation solutions and complete validation lifecycle documentation. The addition of Integral Solutions reflects Verista's continued commitment to delivering best-in-class solutions and services to the pharmaceutical, biotechnology, medical device, and other regulated industries. By combining Verista's nationwide expertise in computer systems validation, commissioning and qualification, manufacturing and packaging automation, machine vision, and regulatory compliance with Integral's depth in engineering and validation, the unified organization will offer clients expanded capacity, deeper technical strength, and integrated project delivery. With the acquisition, Integral Solutions' leadership team, including founder Lou Seich, along with Amy Liddy, Robert Corn, and Wade Cole, and their respective teams, will join Verista. Their experience and long-standing client relationships will help accelerate Verista's growth while ensuring continuity of service and a smooth transition for existing customers. About Verista Verista is a leading provider of integrated end-to-end compliance, validation, and digital enablement for the Life Sciences. Headquartered in Fishers, Indiana, Verista is a one-stop partner that connects regulatory expectations with technical execution and digital transformation. Leveraging innovative technologies and over 500 industry experts, Verista empowers organizations to deliver safe, high-quality products efficiently.

Verista
Apr 8th, 2026
to Showcase COUNTQ and KITQ Innovations at INTERPHEX 2026

Verista to showcase COUNTQ and KITQ innovations at INTERPHEX 2026. Verista, a leading provider of automation, compliance, and quality solutions for the life sciences industry, will highlight its COUNTQ and KITQ integrated offerings at INTERPHEX 2026, April 21-23 at the Jacob Javits Center in New York City, NY, at booth 4139. Underlining the company's focus on helping pharmaceutical and biotech manufacturers improve quality, reduce risk, and accelerate speed to market, these complementary solutions enable more reliable, compliant, and efficient clinical and commercial packaging operations. Verista's COUNTQ system is designed to bring a higher level of confidence and control to component counting and reconciliation processes in packaging workflows, helping manufacturers ensure that counts are accurate and documentation is consistent from batch to batch. Delivering 100% electronic verification of product counts in just 15 seconds using deep learning AI and high-resolution visual inspection with LED lighting, the system provides a processing capacity of up to 100 million vials per year and supports a standard fill line capacity of 300 vials per minute while accommodating various tray types and product sizes without tray templates for quick changeovers and unlimited recipe storage. Fully compliant with 21 CFR Part 11 regulations with a comprehensive audit trail; multiple leading injectable manufacturers, including top pharmaceutical companies and major CMOs, have implemented multiple units across their facilities, achieving improved accuracy, higher throughput, reduced labor costs, and enhanced regulatory compliance. The KITQ system provides reconciliation of complex kit designs to reduce manual effort and errors, as well as electronic management. By combining standardized kit structures with configurable workflows, KITQ provides automated accountability and complete traceability through use of tray-embedded RFID tags, automatic recipe selection, and 21CFR compliant reporting of results. The system integrates seamlessly with existing kit assembly processes and standard operating procedures, helping production managers and manufacturing engineering teams ensure that kit contents are complete, correct, and fully traceable, thereby strengthening compliance and supporting confident decision-making. Together, COUNTQ and KITQ demonstrate Verista's integrated approach to solving critical challenges at the intersection of clinical and commercial operations, giving life sciences companies a more connected view of components, kits, and packaging activities. INTERPHEX attendees are encouraged to stop by booth 4139 to meet with Verista's specialists to discuss how COUNTQ and KITQ can be tailored to their specific environments, from surgical tray setups and medical device spare part kits to large-scale commercial manufacturing. About Verista Verista is a leading provider of integrated end-to-end compliance, validation, and digital enablement for the Life Sciences. Headquartered in Fishers, Indiana, Verista is a one-stop partner that connects regulatory expectations with technical execution and digital transformation. Leveraging innovative technologies and over 500 industry experts, Verista empowers organizations to deliver safe, high-quality products efficiently.

Healthcare Business Today
Mar 22nd, 2026
Verista announces appointment of Michael Laferrera as Chief Executive Officer.

Verista announces appointment of Michael Laferrera as Chief Executive Officer. Verista names seasoned healthcare and pharma services leader as CEO to drive strategic growth, innovation, and operational excellence. Verista, a leading provider of automation, compliance, and quality solutions for the life sciences industry, announces the appointment of Michael J. Laferrera as Chief Executive Officer, bringing to the role a dynamic and purposeful leadership style shaped by more than 35 years of proven success in the competitive healthcare industry. Laferrera is recognized for driving growth, innovation, and profitability as well as leading transformative change across both the pharmaceutical and pharma services sectors. Throughout his career, Laferrera has developed deep expertise in corporate strategy, mergers and acquisitions, organizational transformation, and stakeholder engagement, consistently aligning business vision with strong operational execution. He is known for building high-performance executive teams and fostering cultures of excellence and accountability, qualities that will support Verista's continued expansion and value creation for its clients and stakeholders. Laferrera most recently spent 17 years at Knipper Health, where he served 13 years as President and 5.5 years as Chief Executive Officer, overseeing all strategic and operational activities. Under his leadership, the company saw incredible growth through strategic acquisitions and organic expansion, increasing enterprise value. Discover more Pharmaceuticals & Biotech Consulting "We are excited to welcome Mike to Verista, where we can leverage his vast industry and leadership experience on our journey for expanded growth in 2026 and beyond," said Rich Tabarrini, President of Verista. Earlier in his career, Laferrera held a range of sales and marketing leadership positions within the pharmaceutical industry, building the commercialization and supply chain foundation that has underpinned his success on the pharma services side. Over more than three decades, he became known for leading organizations through inflection points, leveraging change management, digital innovation, and disciplined execution to deliver sustained performance improvements. As Verista's new CEO, Laferrera brings a proven track record of strategic vision, enterprise value creation, and private equity partnership, positioning the company to capitalize on new growth opportunities while strengthening operational excellence. His appointment underscores Verista's commitment to forward-thinking leadership, rigorous performance management, and a culture that rewards collaboration, accountability, and results. When asked about the appointment, Jeff Kinell, Chairman of the Verista Board of Directors, said, "We are thrilled to welcome Mike to the Verista team. He is the right leader at the right time to guide Verista on its journey to provide innovative solutions to the evolving needs of our customers. He is a seasoned CEO who is passionate about driving customer success and building teams. I'm confident that he'll be a tremendous addition to the Verista team. About Verista Verista is a leading provider of integrated end-to-end compliance, validation, and digital enablement for the Life Sciences. Headquartered in Fishers, Indiana, Verista is a one-stop partner that connects regulatory expectations with technical execution and digital transformation. Leveraging innovative technologies and over 500 industry experts, Verista empowers organizations to deliver safe, high-quality products efficiently. The Editorial Team at Healthcare Business Today is made up of experienced healthcare writers and editors, led by managing editor Daniel Casciato, who has over 25 years of experience in healthcare journalism. Since 1998, our team has delivered trusted, high-quality health and wellness content across numerous platforms. Disclaimer: The content on this site is for general informational purposes only and is not intended as medical, legal, or financial advice. No content published here should be construed as a substitute for professional advice, diagnosis, or treatment. Always consult with a qualified healthcare or legal professional regarding your specific needs. See our full disclaimer for more details.

Healthcare Packaging
Mar 16th, 2026
Computer Systems Validation Services

Computer Systems Validation services. Verista's comprehensive CSV services offer expert-led validation to ensure regulatory compliance, efficiency, and data integrity across the life sciences industry. Mar 16, 2026 This content was written and submitted by the supplier. It has only been modified to comply with this publication's space and style. Verista, a provider of automation, compliance, and quality solutions for the life sciences industry, highlights their specialized Computer Systems Validation (CSV) services designed to support every phase of the product lifecycle, from research and clinical testing to manufacturing and distribution. CSV is a complex, multi-faceted function that encompasses a broad range of validated computer systems throughout the entire business. From research and clinical testing to manufacturing and distribution, CSV plays a critical role at every stage. The increasing adoption of cloud-based systems alongside traditional on-premise solutions has introduced new layers of complexity, making it even more challenging for organizations to maintain compliance. Verista addresses this challenge by offering managed services that seamlessly integrate quality and compliance functions, including vendor auditing and computer system validation testing. Verista's CSV offering spans the full scope of validated systems across the enterprise. The company enables clients to streamline their validation programs by wrapping quality and compliance functions into a managed services model. This approach ensures that validation, from vendor auditing through testing, is carried out with precision, agility, and audit-readiness. Clients gain measurable value through Verista's expert insight and services, including custom implementations, agile project and audit management, and strategic tool integration. With Verista's support, companies transform their review and approval processes while maintaining compliance and strengthening operational efficiency. The company also offers expert training and ongoing system maintenance, reinforcing best-in-class practices and long-term success. By partnering with Verista, life sciences organizations can confidently implement robust CSV processes that ensure accuracy, reliability, and consistency while safeguarding data integrity and achieving regulatory compliance across all systems and platforms. Companies in this product You're Invited! Don't miss your weekly dose of packaging intelligence and news with Healthcare Packaging's e-newsletter.

Contract Pharma
Mar 13th, 2026
Verista Acquires Integral Solutions

Verista acquires Integral Solutions. The unified organization aims to offer clients expanded capacity, deeper technical strength, and integrated project delivery. March 13, 2026 Associate Editor Verista, a provider of automation, compliance, and quality solutions for the life sciences industry, has acquired Integral Solutions, a life sciences business and technology services firm that specializes in engineering and validation services worldwide. The acquisition enhances Verista's capabilities in automation, engineering, project management, and validation, enabling the company to deliver further comprehensive support across the full lifecycle of regulated life sciences operations. By combining Verista's nationwide expertise in computer systems validation, commissioning and qualification, manufacturing and packaging automation, machine vision, and regulatory compliance with Integral's depth in engineering and validation, the unified organization aims to offer clients expanded capacity, deeper technical strength, and integrated project delivery. With the acquisition, Integral Solutions' leadership team, including founder Lou Seich, along with Amy Liddy, Robert Corn, and Wade Cole, and their respective teams, will join Verista. Their experience and long-standing client relationships will help accelerate Verista's growth while ensuring continuity of service and a smooth transition for existing customers.